EP1515748A4
Anti-estrogen and immune modulator combinations for treating breast cancer
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 13 November 2022, 3.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| EP1366366A2 | Cites | European Patent Office (EPO) | E | Search report | 1-28 |
| US4859585A | Cites | United States of America | – | Search report | – |
| US4919937A | Cites | United States of America | – | Search report | – |
| EP1366366A | Cites | European Patent Office (EPO) | – | – | – |
| BRODIE A ET AL: "Aromatase inhibitors and their antitumor effects in model systems.", ENDOCRINE-RELATED CANCER. JUN 1999, vol. 6, no. 2, June 1999 (1999-06-01), pages 205 - 210, XP002367011, ISSN: 1351-0088 | Non-patent | – | – | Search report | – |
| ROSSO R ET AL: "ADJUVANT SYSTEMIC TREATMENT OF RESECTABLE BREAST CANCER ELEVEN YEARS RESULTS OF A MONOINSTITUTIONAL CHEMO-HORMONE-IMMUNOTHERAPY TRIAL", ANTICANCER RESEARCH, vol. 9, no. 4, 1989, pages 1153 - 1156, XP008057015, ISSN: 0250-7005 | Non-patent | – | – | Search report | – |
| SAWAI K ET AL: "CHEMO-ENDOCRINE-IMMUNOTHERAPY WITH ADRIAMYCIN TAMOXIFEN AND OK-432 PICIBANIL FOR ADVANCED BREAST CANCER", JOURNAL OF JAPAN SOCIETY FOR CANCER THERAPY, vol. 19, no. 6, 1984, pages 1315 - 1320, XP008057016, ISSN: 0021-4671 | Non-patent | – | – | Search report | – |
| MCCORMICK DAVID L ET AL: "Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland", CANCER RESEARCH, vol. 56, no. 8, 1996, pages 1724 - 1726, XP008057031, ISSN: 0008-5472 | Non-patent | – | – | Search report | – |
| SAVAGE P ET AL: "A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily", BRITISH JOURNAL OF CANCER, vol. 74, no. 9, 1996, pages 1482 - 1486, XP002073161, ISSN: 0007-0920 | Non-patent | – | – | Search report | – |
66 members in 8 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 332801P | United States of America | – | |
| 33280101 | United States of America | P | |
| 33280101 | United States of America | P | |
| 0236633 | United States of America | W | |
| 0236633 | United States of America | W | |
| 332801P | – | – | – |
| US20010332801P | – | – | – |
| US2002036633 | – | – | – |
| WO2002US36633 | – | – | – |
Members66
| Document | Office | Kind | |
|---|---|---|---|
| CA2409150A1 | Canada | A1 | |
| CA2409765A1 | Canada | A1 | |
| CA2803844A1 | Canada | A1 | |
| CA2804977A1 | Canada | A1 | |
| WO0185210A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0186307A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6969001A | Australia | A | |
| AU7290801A | Australia | A | |
| US2002006630A1 | United States of America | A1 | |
| US2002012954A1 | United States of America | A1 | |
| US2003059433A1 | United States of America | A1 | |
| US2003072760A1 | United States of America | A1 | |
| US2003072812A1 | United States of America | A1 | |
| WO0185210A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03041654A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03042404A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03042660A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002343704A1 | Australia | A1 | |
| AU2002343714A1 | Australia | A1 | |
| AU2002359401A1 | Australia | A1 | |
| EP1328293A2 | European Patent Office (EPO) | A2 | |
| WO0186307A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1366366A2 | European Patent Office (EPO) | A2 | |
| WO03042404A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03042660A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA02011092A | Mexico | A | |
| MXPA02011092A | Mexico | A | |
| MXPA02011093A | Mexico | A | |
| MXPA02011093A | Mexico | A | |
| EP1490502A2 | European Patent Office (EPO) | A2 | |
| WO03041654A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1515748A2 | European Patent Office (EPO) | A2 | |
| EP1530720A2 | European Patent Office (EPO) | A2 | |
| EP1490502A4 | European Patent Office (EPO) | A4 | |
| EP1530720A4 | European Patent Office (EPO) | A4 | |
| EP1515748A4This record | European Patent Office (EPO) | A4 | |
| US2008226549A1 | United States of America | A1 | |
| EP1366366B1 | European Patent Office (EPO) | B1 | |
| US2010278729A9 | United States of America | A9 | |
| AT485520T | Austria | T | |
| ATE485520T1 | Austria | T1 | |
| DE60143320D1 | Germany | D1 | |
| US2010303825A9 | United States of America | A9 | |
| US7863011B2 | United States of America | B2 | |
| US2011014206A9 | United States of America | A9 | |
| EP2299265A1 | European Patent Office (EPO) | A1 | |
| EP2306187A1 | European Patent Office (EPO) | A1 | |
| US2011086800A1 | United States of America | A1 | |
| US7947275B2 | United States of America | B2 | |
| US7947463B2 | United States of America | B2 | |
| EP2359857A2 | European Patent Office (EPO) | A2 | |
| US8038999B2 | United States of America | B2 | |
| EP2394659A1 | European Patent Office (EPO) | A1 | |
| EP2394660A1 | European Patent Office (EPO) | A1 | |
| US2012028258A1 | United States of America | A1 | |
| US2012034206A1 | United States of America | A1 | |
| EP1328293B1 | European Patent Office (EPO) | B1 | |
| US8119138B2 | United States of America | B2 | |
| EP2359857A3 | European Patent Office (EPO) | A3 | |
| AT545433T | Austria | T | |
| ATE545433T1 | Austria | T1 | |
| US2012115161A1 | United States of America | A1 | |
| US2012121620A1 | United States of America | A1 | |
| EP1490502B1 | European Patent Office (EPO) | B1 | |
| US8563249B2 | United States of America | B2 | |
| EP2394659B1 | European Patent Office (EPO) | B1 |
13 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Request for examination filed17P | 17P | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1515748
- Publication, DOCDB
- 1515748
- Publication, EPODOC
- EP1515748
- Application
- 2793936
- Application, DOCDB
- 02793936
- Application, EPODOC
- EP20020793936
Titles3
- German
- ANTIÖSTROGEN UND IMMUNMODULATOR-KOMBINATIONEN ZUR BEHANDLUNG VON BRUSTKREBS
- English
- ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
- French
- COMBINAISONS D'ANTIOESTROGENES ET D'IMMUNOMUDULATEURS POUR TRAITER LE CANCER DU SEIN
Classification
- CPC, 11
- G01N33/57515
- A61K31/00
- A61K31/138
- A61K31/429
- A61K31/4745
- A61K31/5685
- A61K45/06
- A61K48/00
- G01N2333/70503
- A61K38/1774
- G01N33/575
- IPC, 10
- A61K39 395
- G01N33 53
- A61K31 00
- A61K31 138
- A61K31 429
- A61K31 4745
- A61K31 5685
- A61K35 74
- A61K45 06
- G01N33 574
Designated states1
- Contracting states, 1
- Türkiye